본문 바로가기
KERD
논문KCI 등재

2005년 암의 경제적 비용부담 추계

Economic Burden of Cancer in South Korea for the Year 2005

1

조회

0

다운로드

34

인용

0

참고문헌

키워드

초록

Objectives : The objective of this study is to estimate the economic costs of cancer on society. Methods : We estimated the economic burden of people with cancer in South Korea. To perform the analysis, we reviewed the records of people who were cancer patients and those who were newly diagnosed with cancer. The data was compiled from the National Health Insurance Corporation, which included the insurance claims database, a list of cancer patients, a database that records the cancer rates, the Korea Central Cancer Registry Center s cancer patient registry database and the Korea National Statistical Office s causes of death database. We classified the costs as related to cancer into direct costs and indirect costs, and we estimated each cost. Direct costs included both medical and non-medical care expenses and the indirect costs consisted of morbidity, mortality and the caregiver s time costs. Results : The total economic costs of cancer in South Korea stood at 14.1 trillion won in 2005. The largest amount of the cost 7.4 trillion won, was the mortality costs. Following this were the morbidity costs (3.2 trillion won), the medical care costs (2.2 trillion won), the non-medical care costs (1.1 trillion won) and the costs related to the caregiver s time (100 billion won). As a result, the economic cost of cancer to South Korea is estimated to be between 11.6 trillion won to 14.1 trillion won for the year 2005. Conclusions : We need to reduce the cancer burden through encouraging people to undergo early screening for cancer and curing it in the early stage of cancer, as well as implementing policies to actively prevent cancer.

Abstract

Objectives : The objective of this study is to estimate the economic costs of cancer on society. Methods : We estimated the economic burden of people with cancer in South Korea. To perform the analysis, we reviewed the records of people who were cancer patients and those who were newly diagnosed with cancer. The data was compiled from the National Health Insurance Corporation, which included the insurance claims database, a list of cancer patients, a database that records the cancer rates, the Korea Central Cancer Registry Center s cancer patient registry database and the Korea National Statistical Office s causes of death database. We classified the costs as related to cancer into direct costs and indirect costs, and we estimated each cost. Direct costs included both medical and non-medical care expenses and the indirect costs consisted of morbidity, mortality and the caregiver s time costs. Results : The total economic costs of cancer in South Korea stood at 14.1 trillion won in 2005. The largest amount of the cost 7.4 trillion won, was the mortality costs. Following this were the morbidity costs (3.2 trillion won), the medical care costs (2.2 trillion won), the non-medical care costs (1.1 trillion won) and the costs related to the caregiver s time (100 billion won). As a result, the economic cost of cancer to South Korea is estimated to be between 11.6 trillion won to 14.1 trillion won for the year 2005. Conclusions : We need to reduce the cancer burden through encouraging people to undergo early screening for cancer and curing it in the early stage of cancer, as well as implementing policies to actively prevent cancer.

참고문헌 (39)

  1. World Cancer Report. Lyon: IARC Press, "Stewart BW", ~ (2003)
  2. Ngoma T, "World Health Organization cancer priorities in developing countries", Ann Oncol, 17(8), pp.viii9~viii14 (2006)
  3. "Korean Statistical Information Service"[URL]
  4. National Cancer Center, "Cancer Facts & Figures 2008" (2008)
  5. "Ministry for Health"[URL]
  6. Brown ML, "The burden of illness of cancer: Economic cost and quality of life", Annu Rev Public Health, 22, pp.91~113 (2001)
  7. Rice DP, "The economic costs of illness: A replication and update", Health Care Financ Rev, 7(1), pp.61~80 (1985)
  8. Max W, "The economic burden of prostate cancer, California, 1998", Cancer, 94(11), pp.2906~2913 (2002)
  9. Pickle LW, "A new method of estimating United States and state-level cancer incidence counts for the current calender year", CA Cancer J Clin, 57(1), pp.30~42 (2007)
  10. "Cancer Facts & Figures"[URL]
  11. "Cancer Facts & Figures"[URL]
  12. 박춘선, "건강보험 청구자료를 이용한 우리나라 천식환자의 질병비용부담 추계", 예방의학회지, 39(5), pp.397~403 (2006), 대한예방의학회
  13. Yang BM, "Direct and Indirect Costs of Hepatitis B in Korea" (2000), The Korea Association of Health Economics and Policy
  14. Kim HJ, "Analysis of socioeconomic costs of smoking in Korea", Korean J Prev Med, 34(3), pp.183~190 (2001)
  15. Jung YH, "Estimating socioeconomic costs of five major disease", Korean J Public Finance, 18(2), pp.77~104 (2004)
  16. Kim SG, "The economic burden of cancer in Korea in 2002", Eur J Cancer Care (Engl), 17(2), pp.136~144 (2008)
  17. You GC, "Determinants and Macroefficiency of the National Health Expenditure" (2003), Korea Institute for Health and Social Affairs
  18. 이건세, "보건의료 경제성 평가 방법론 고찰 - 연구 설계와 비용 추정을 중심으로 -", 보건행정학회지, 14(2), pp.58~77 (2004), 한국보건행정학회
  19. 강혜영, "크레메진의 투석도입 지연효과에 따른 진행성 신부전증환자의 비용감소분 추계", 예방의학회지, 39(2), pp.149~158 (2006), 대한예방의학회
  20. Drummond MF, "Methods for the Economic Evaluation of Health Care Programmes" (2005), Oxford University Press
  21. 정백근, "한국인 성인 비만의 사회경제적 비용", 예방의학회지, 35(1), pp.1~12 (2002), 대한예방의학회
  22. Hogan P, "Economic costs of diabetes in the US in 2002", Diabetes Care, 26(3), pp.917~932 (2003)
  23. Hoffman C, "Persons with chronic conditions: Their prevalence and costs", JAMA, 276(18), pp.1473~1479 (1996)
  24. Kim JH, "A Survey About Out-of-pocket Expenditure of Patients Enrolled in Health Insurance in Year 2005" (2006), National Health Insurance Corporation
  25. Park EC, "A Study on the Estimation of Cost Related to Cancer Care and Burden of Cancer Diseases" (2003), National Cancer Center
  26. "The Third Korea National Health and Nutrition Examination Survey (KNHANES)"[URL]
  27. "Association of Sarangnanum Medicare Service; c1999-2006"[URL]
  28. Park EC, "Evaluation of Cancer Screening and Cost of Cancer" (2005), National Cancer Center
  29. Park EC, "Evaluation of Cancer Screening and Cost of Cancer" (2006), National Cancer Center
  30. Chang SB, "Cost Analysis and Classification of Complementary and Alternative Therapies used by Cancer patients in Korea" (2005), Ministry for Health, Welfare and Family Affairs
  31. Park EC, "Evaluation of Cancer Screening and Cost of Cancer", National Cancer Center (2004)
  32. Jung YH, "An estimation of lost earnings attributable to cancer-induced deaths", Welf Fam Aff, 67, pp.69~80 (2002)
  33. National Health Insurance Corporation, "2006 National Health Insurance Statistical Yearbook" (2007)
  34. "Economic Statistic System"[URL]
  35. Kim TI, "Analysis on the differences in medical service usage in terms ofincome levels", Soc Secur Res, 24(3), pp.53~75 (2008)
  36. "Ministry for Health, Welfare and Family Affairs"[URL]
  37. Yabroff KR, "Burden of illness in cancer survivors: Findings from a population-based national sample", J Natl Cancer Inst, 96(17), pp.1322~1330 (2004)
  38. Max W, "The economic burden of prostate cancer, California, 1998", Cancer, 94(11), pp.2906~2913 (2002)
  39. Brown ML, "Economic impact of cancer in the United States, in: Schottenfeld D, Fraumini JF, editors. Cancer Epidemiology and Prevention", pp.255~266 (1996), Oxford University Press

관련 논문AI추천

이 간행물의 다른 논문 (7건)